While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient option: A pill. Novo Nordisk already makes semaglutide ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
Shares in chipmaker Advanced Micro Devices (AMD) had also slumped in after-hours trading, falling nearly 9% before market open on Wednesday. While AMD (AMD) delivered strong fourth quarter ...
U.S. stock futures point lower as investors evaluate disappointing tech earnings, shares of Alphabet drop as the Google ...
GlobalData on MSN8d
Novo Nordisk plans new study for CagriSema, targets 2026 submissionCagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...
LONDON, Feb 5 (Reuters) - Wegovy maker Novo Nordisk (NOVOb.CO), opens new tab is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, its chief executive ...
Novo Nordisk’s CEO toasted the company’s record-breaking profitability and earnings on Wednesday morning as the group behind Ozempic and Wegovy put on a brave face about its ability to fight ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback